TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36074934

Group type: EXPERIMENTAL
Intervention: LED photobiomodulation therapy (PBMT) with red (630 nm) and infrared (850 nm) wavelengths
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (right side of abdomen, no treatment)
Number of subjects: 0
Study: 33914197

Group type: EXPERIMENTAL
Intervention: Insulin (INS) intervention
Number of subjects: 8

Group type: COMPARATOR
Intervention: Carbohydrates (CARBS) intervention
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 8
Study: 34897211

Group type: EXPERIMENTAL
Intervention: Topical metronidazole ointment
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oral metronidazole
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (oral placebo)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (topical placebo)
Number of subjects: 120
Study: 33080379

Group type: EXPERIMENTAL
Intervention: Decídetexto mobile smoking cessation intervention
Number of subjects: 618

Group type: COMPARATOR
Intervention: Standard of care (printed smoking cessation materials and referral to telephone quitline)
Number of subjects: 618
Study: 33714500

Group type: EXPERIMENTAL
Intervention: Suboccipital fascial release (SFR) technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (untreated group, UG)
Number of subjects: 40
Study: 33036567

Group type: EXPERIMENTAL
Intervention: Supervised home-based standardized physical activity program for 3 months
Number of subjects: 432

Group type: COMPARATOR
Intervention: Recommended adapted physical activity (via a booklet)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Supervised home-based standardized physical activity program
Number of subjects: 432
Study: 33086883

Group type: EXPERIMENTAL
Intervention: Risk score based on candidate predictors (age at admission, socioeconomic status, family history of asthma/atopy, previous asthma hospitalizations)
Number of subjects: 1171

Group type: COMPARATOR
Intervention: Not applicable (comparison group in general ward)
Number of subjects: 1171
Study: 33642048

Group type: EXPERIMENTAL
Intervention: Ankle-brachial index (ABI) measurement
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Barriers to ABI measurement
Number of subjects: 92
Study: 32757427

Group type: EXPERIMENTAL
Intervention: Audit with feedback on a quarterly basis over a 12-month implementation period.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quarterly audits only (without feedback).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined data from both groups.
Number of subjects: 0
Study: 36121706

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI
Number of subjects: 757

Group type: COMPARATOR
Intervention: Intravascular imaging guidance
Number of subjects: 757
Study: 33933030

Group type: EXPERIMENTAL
Intervention: Quality Circle Deprescribing Module (QC-DeMo) intervention
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 58
Study: 33534231

Group type: EXPERIMENTAL
Intervention: Biological mesh closure
Number of subjects: 104

Group type: COMPARATOR
Intervention: Primary perineal closure
Number of subjects: 104
Study: 33130139

Group type: EXPERIMENTAL
Intervention: Single burr hole
Number of subjects: 192

Group type: COMPARATOR
Intervention: Double burr hole
Number of subjects: 192
Study: 35815264

Group type: EXPERIMENTAL
Intervention: Er Xian Decoction combined with Baduanjin Exercise (EXD + BE)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Er Xian Decoction (EXD)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Baduanjin Exercise (BE)
Number of subjects: 50
Study: 33334164

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behaviour therapy for insomnia (CBT-I)
Number of subjects: 21
Study: 35482129

Group type: EXPERIMENTAL
Intervention: 1565-nm non-ablative fractional laser combined with low-dose compound betamethasone topical application
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 38
Study: 32352812

Group type: EXPERIMENTAL
Intervention: Checklist assessment of NSSI history
Number of subjects: 1364

Group type: COMPARATOR
Intervention: Single-item assessment of NSSI history
Number of subjects: 1364
Study: 34856530

Group type: EXPERIMENTAL
Intervention: 0.8 FiO2 (80% oxygen)
Number of subjects: 258

Group type: COMPARATOR
Intervention: 0.3 FiO2 (30% oxygen)
Number of subjects: 258
Study: 33686698

Group type: EXPERIMENTAL
Intervention: Chronically elevated GDF15 levels
Number of subjects: 0
Study: 32537715

Group type: EXPERIMENTAL
Intervention: Fedratinib 500 mg once-daily for 15 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no fedratinib)
Number of subjects: 0
Study: 35997691

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 0
Study: 33684828

Group type: EXPERIMENTAL
Intervention: Pro Kind home visitation program
Number of subjects: 109
Study: 32635661

Group type: EXPERIMENTAL
Intervention: Synbiotic preparation containing Lactobacillus and Bifidobacterium strains and fructooligosaccharides
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Synbiotic preparation
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Synbiotic treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 36067791

Group type: EXPERIMENTAL
Intervention: Honglilai Vaginal Cream (0.625 mg/g) once daily for 3 weeks
Number of subjects: 435

Group type: COMPARATOR
Intervention: Premarin Vaginal Cream (0.625 mg/g) once daily for 3 weeks
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Honglilai Vaginal Cream
Number of subjects: 435

Group type: COMPARATOR
Intervention: Premarin Vaginal Cream
Number of subjects: 435
Study: 32401633

Group type: EXPERIMENTAL
Intervention: CPX-351 (135 units/m2 on days 1, 3, and 5)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: FLAG (fludarabine 30 mg/m2/dose on days 1-5; cytarabine 2000 mg/m2/dose on days 1-5; granulocyte-colony stimulating factor 5 mg/kg/dose, days 1-5 and day 15)
Number of subjects: 38
Study: 33509414

Group type: EXPERIMENTAL
Intervention: STAND intervention (N = 84)
Number of subjects: 179

Group type: COMPARATOR
Intervention: TSP intervention (N = 95)
Number of subjects: 179
Study: 33191253

Group type: EXPERIMENTAL
Intervention: Dementia cases
Number of subjects: 291780
Study: 35364620

Group type: EXPERIMENTAL
Intervention: Values-based cognitive behavioural therapy (V-CBT) delivered within 6 months post-injury, 10 sessions starting 1 week post-randomization (group A)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Values-based cognitive behavioural therapy (V-CBT) delivered within 6 months post-injury, 10 sessions starting 3 months post-randomization (group B)
Number of subjects: 91
Study: 33690227

Group type: EXPERIMENTAL
Intervention: Training data group (drugs with known pharmacokinetic and physical parameters)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Test data group (validation of the prediction equation)
Number of subjects: 70
Study: 32952016

Group type: EXPERIMENTAL
Intervention: CoEDTA
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: CrEDTA
Number of subjects: 2

Group type: COMPARATOR
Intervention: RedSol (reducing solution)
Number of subjects: 2
Study: 35471721

Group type: EXPERIMENTAL
Intervention: LY2963016 insulin glargine (LY IGlar)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Insulin glargine (IGlar)
Number of subjects: 210
Study: 35871064

Group type: EXPERIMENTAL
Intervention: KEβHB drink
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 18
Study: 32505857

Group type: EXPERIMENTAL
Intervention: 200 mL retained cystoscopy fluid
Number of subjects: 120

Group type: COMPARATOR
Intervention: Complete bladder emptying
Number of subjects: 120
Study: 32059694

Group type: EXPERIMENTAL
Intervention: Informed Health Choices podcast
Number of subjects: 523

Group type: COMPARATOR
Intervention: Control (typical public service announcements about health issues)
Number of subjects: 523
Study: 35436968

Group type: EXPERIMENTAL
Intervention: Leg swing exercise
Number of subjects: 114

Group type: COMPARATOR
Intervention: Quadriceps strengthening exercise
Number of subjects: 114
Study: 33866315

Group type: EXPERIMENTAL
Intervention: Test formulation (0.12 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 0
Study: 35503610

Group type: EXPERIMENTAL
Intervention: Medihoney dressing material applied to the donor site in the test group
Number of subjects: 20

Group type: COMPARATOR
Intervention: No dressing material applied in the control group
Number of subjects: 20
Study: 32360392

Group type: EXPERIMENTAL
Intervention: Active tDCS with cognitive training (CT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham tDCS with cognitive training (CT)
Number of subjects: 44
Study: 33772416

Group type: EXPERIMENTAL
Intervention: Reading intervention
Number of subjects: 216

Group type: COMPARATOR
Intervention: ADHD treatment
Number of subjects: 216

Group type: COMPARATOR
Intervention: Combined treatments
Number of subjects: 216

Group type: COMPARATOR
Intervention: ADHD intervention
Number of subjects: 216
Study: 36128948

Group type: EXPERIMENTAL
Intervention: 21 mm circular stapler (CSD)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 45 mm linear stapler (LSD)
Number of subjects: 20
Study: 32196804

Group type: EXPERIMENTAL
Intervention: Multicomponent balance‐specific exercise programme with additional workshops on active and healthy ageing, N = 50
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Multicomponent wellness programme, N = 50
Number of subjects: 150

Group type: COMPARATOR
Intervention: Regular Special Olympics athletic training, N = 50
Number of subjects: 150
Study: 34444940

Group type: EXPERIMENTAL
Intervention: Food Addiction (FA)
Number of subjects: 448

Group type: COMPARATOR
Intervention: No Food Addiction (non-FA)
Number of subjects: 448
Study: 34066238

Group type: EXPERIMENTAL
Intervention: Food Frequency Questionnaire (FFQ)
Number of subjects: 150
Study: 32865690

Group type: EXPERIMENTAL
Intervention: Superior calyceal access (group 1)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Inferior calyceal access (group 2)
Number of subjects: 126
Study: 32663977

Group type: EXPERIMENTAL
Intervention: ESC/MEM
Number of subjects: 41

Group type: COMPARATOR
Intervention: ESC/PBO
Number of subjects: 41
Study: 35850141

Group type: EXPERIMENTAL
Intervention: Modified low dose protocol with tin filtering
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional low dose protocol without tin filtering
Number of subjects: 65
Study: 34023839

Group type: EXPERIMENTAL
Intervention: Xerostomia Inventory (XI)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Xerostomia Inventory (XI) as a gold standard
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Logistical regression model adjusted for tooth mobility, bone or respiratory diseases, and consumption of anxiolytics and antidepressants
Number of subjects: 354
Study: 35689905

Group type: EXPERIMENTAL
Intervention: Motivational interviewing counseling plus nicotine replacement therapy (NRT)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Brief advice to quit (standard care) plus NRT
Number of subjects: 324
Study: 32723318

Group type: EXPERIMENTAL
Intervention: Usual case management plus motivational interviewing (MI)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Usual case management plus stratified vocational advice intervention (SVAI)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Usual case management alone
Number of subjects: 450
Study: 36166567

Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI) + Action Observation (AO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VR-based MI training system with EMG feedback
Number of subjects: 0
Study: 33067258

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB) treatment with small-size balloon predilation (pBVR<0.8)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB) treatment with large-size balloon predilation (pBVR 0.8-1.0)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Follow-up for long-term outcomes
Number of subjects: 30
Study: 32204222

Group type: EXPERIMENTAL
Intervention: Aspirin 80mg plus pravastatin 20mg twice daily until 35 weeks gestation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin 80mg
Number of subjects: 0
Study: 35365190

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) applied once at the level of the lesion, five segments above/below, and on the plantar surface of both feet within the first 48 h after trauma (energy flux density: 0.1–0.19 mJ/mm2, frequency: 2–5 Hz)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 82
Study: 33542265

Group type: EXPERIMENTAL
Intervention: Active tRNS
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham tRNS
Number of subjects: 19
Study: 32460879

Group type: EXPERIMENTAL
Intervention: Ondansetron oral solution (six doses over 48 hours)
Number of subjects: 1030

Group type: COMPARATOR
Intervention: Placebo (six doses over 48 hours)
Number of subjects: 1030
Study: 35695006

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160

Group type: COMPARATOR
Intervention: 40 mg Revacept
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 120 mg Revacept
Number of subjects: 160
Study: 33788003

Group type: EXPERIMENTAL
Intervention: WHO grading scale
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: WHO vs RTOG
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: WHO vs CTCAE
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: CTCAE vs RTOG
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: CTCAE assessments for severe OM (WHO score ≥ 3)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: RTOG assessments for severe OM (WHO score ≥ 3)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Patients with WHO score of 4
Number of subjects: 200
Study: 32029375

Group type: EXPERIMENTAL
Intervention: Barium sulfate shield
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bismuth‐antimony shield
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topogram‐based tube current modulation (TCM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed tube current
Number of subjects: 0
Study: 35075525

Group type: EXPERIMENTAL
Intervention: Structured behavioral support program with 7-weekly sessions
Number of subjects: 128

Group type: COMPARATOR
Intervention: Routine post-operative care (control group)
Number of subjects: 128
Study: 33048877

Group type: COMPARATOR
Intervention: $0 financial incentive
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: $1.25 financial incentive
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: $2.50 financial incentive
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: $5.00 financial incentive
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: $10.00 financial incentive
Number of subjects: 452
Study: 33177479

Group type: EXPERIMENTAL
Intervention: Patients with chronic rotator cuff tears (n=12)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Age-matched controls (n=11)
Number of subjects: 23
Study: 32078469

Group type: EXPERIMENTAL
Intervention: Acetazolamide (500 mg twice a day for 3 days)
Number of subjects: 16
Study: 33843798

Group type: EXPERIMENTAL
Intervention: Physical activity intervention with aerobic activity and inspiratory muscle training 2 weeks pre- and 4 weeks postoperatively
Number of subjects: 668

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 668
Study: 32193187

Group type: EXPERIMENTAL
Intervention: Golimumab plus MTX
Number of subjects: 44

Group type: COMPARATOR
Intervention: MTX monotherapy
Number of subjects: 44
Study: 35179037

Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir arm
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: ART initiation
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Grayscale ultrasound measures
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Grayscale median
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Gray-level difference statistic-contrast
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Entropy
Number of subjects: 201
Study: 33784522

Group type: EXPERIMENTAL
Intervention: Telestroke consultation with a hub vascular neurologist
Number of subjects: 257

Group type: COMPARATOR
Intervention: Care provided by local neurologists (pre-cohort)
Number of subjects: 257
Study: 35094632

Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 51
Study: 32829526

Group type: EXPERIMENTAL
Intervention: Low-intensity isometric handgrip exercise
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Moderate-intensity isometric handgrip exercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: Regular HD (Control)
Number of subjects: 8
Study: 32926507

Group type: EXPERIMENTAL
Intervention: pembrolizumab 200 mg every 3 weeks (35 cycles)
Number of subjects: 40

Group type: COMPARATOR
Intervention: chemotherapy (four to six cycles)
Number of subjects: 40
Study: 35130196

Group type: EXPERIMENTAL
Intervention: Lidocaine 2%
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bupivacaine 0.5%
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Single injection
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dual injection
Number of subjects: 36
Study: 34533816

Group type: EXPERIMENTAL
Intervention: Mirror therapy (MT) with taping
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Modified constraint‐induced movement therapy (mCIMT) alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mirror therapy (MT) alone
Number of subjects: 60
Study: 34098301

Group type: EXPERIMENTAL
Intervention: MOUD (Medication for Opioid Use Disorder)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: XR-NTX (Extended-Release Naltrexone)
Number of subjects: 570

Group type: COMPARATOR
Intervention: BUP-NX (Buprenorphine-Naloxone)
Number of subjects: 570

Group type: COMPARATOR
Intervention: Not on MOUD
Number of subjects: 570
Study: 32372454

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 12637

Group type: EXPERIMENTAL
Intervention: Semaglutide
Number of subjects: 12637

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12637
Study: 34344198

Group type: EXPERIMENTAL
Intervention: Mailed DVD
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Mailed DVD plus patient navigation
Number of subjects: 371

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 371
Study: 34268738

Group type: EXPERIMENTAL
Intervention: Articaine
Number of subjects: 160

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 160
Study: 32020631

Group type: EXPERIMENTAL
Intervention: Early position change 1 hour after sheath removal
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 36416379

Group type: EXPERIMENTAL
Intervention: Cryoprecipitate (10 units before incision)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (0.9% saline equivalent volume)
Number of subjects: 80
Study: 33063203

Group type: EXPERIMENTAL
Intervention: Statin group (n=650)
Number of subjects: 2536

Group type: COMPARATOR
Intervention: No-statin group (n=1886)
Number of subjects: 2536
Study: 32928177

Group type: EXPERIMENTAL
Intervention: 177Lu‐PSMA‐I&T
Number of subjects: 58

Group type: COMPARATOR
Intervention: Deferred ADT (standard of care)
Number of subjects: 58
Study: 35425746

Group type: EXPERIMENTAL
Intervention: Resilience-based intervention
Number of subjects: 1120
Study: 34602484

Group type: EXPERIMENTAL
Intervention: B vitamin therapy (daily folic acid 0.8 mg, vitamin B12 0.5 mg, vitamin B6 20 mg)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 266
Study: 35352235

Group type: EXPERIMENTAL
Intervention: Vocal music
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Instrumental music
Number of subjects: 38

Group type: COMPARATOR
Intervention: Audiobooks
Number of subjects: 38
Study: 33228472

Group type: EXPERIMENTAL
Intervention: School-based physical-activity intervention (Active School) including two 45 min physically active lessons, five 10 min physically active breaks, and five 10 min physically active homework.
Number of subjects: 435

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 435
Study: 32290829

Group type: EXPERIMENTAL
Intervention: Oral dextrose
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Facilitated tucking
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine method (no pain relief)
Number of subjects: 60
Study: 36193322

Group type: EXPERIMENTAL
Intervention: Fu's subcutaneous needling therapy (FSN), treated once every other day for 5 consecutive treatments.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Acupuncture, treated once a day for 10 consecutive treatments.
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: FSN and Acupuncture (both groups).
Number of subjects: 72
Study: 32469835

Group type: EXPERIMENTAL
Intervention: Modified group cognitive behavioral therapy (CBT), 8 weekly sessions of 60 minutes each
Number of subjects: 82

Group type: COMPARATOR
Intervention: Treatment-as-usual (Control)
Number of subjects: 82
Study: 34792804

Group type: EXPERIMENTAL
Intervention: 100 mg caffeine
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Stress
Number of subjects: 181

Group type: COMPARATOR
Intervention: No stress
Number of subjects: 181
Study: 32475292

Group type: EXPERIMENTAL
Intervention: Norrbotten (13.2%), Seinäjoki‐Vaasa (14.8%), Helsinki (14.4%)
Number of subjects: 34072

Group type: EXPERIMENTAL
Intervention: Norrbotten (13.0%)
Number of subjects: 34072

Group type: EXPERIMENTAL
Intervention: Finnish areas (7.7–8.2%)
Number of subjects: 34072

Group type: EXPERIMENTAL
Intervention: 1.7% to 2.7%
Number of subjects: 34072

Group type: EXPERIMENTAL
Intervention: Norrbotten
Number of subjects: 34072

Group type: EXPERIMENTAL
Intervention: Västra Götaland and Seinäjoki‐Vaasa
Number of subjects: 34072

Group type: EXPERIMENTAL
Intervention: More women than men
Number of subjects: 34072

Group type: EXPERIMENTAL
Intervention: No sex differences
Number of subjects: 34072

Group type: EXPERIMENTAL
Intervention: Opposite found in Finland
Number of subjects: 34072
Study: 32367446

Group type: EXPERIMENTAL
Intervention: TELEM group (telementoring)
Number of subjects: 65

Group type: COMPARATOR
Intervention: LIVE group (live proctor)
Number of subjects: 65
Study: 35856326

Group type: EXPERIMENTAL
Intervention: Vibratory anesthesia
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Vapocoolant (cold) spray
Number of subjects: 180

Group type: COMPARATOR
Intervention: Injection without anesthesia
Number of subjects: 180
Study: 34222115

Group type: EXPERIMENTAL
Intervention: Midwife-led psycho-education intervention (four sessions: two group sessions during pregnancy and two individual sessions after delivery)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 66